Skip to content

ClearPoint Neuro, Inc.: 10-Q filed 2017-11-06

What ClearPoint Neuro, Inc. reported in its quarterly report filed 2017-11-06 (fiscal Q3 2017): 31 published measures, 79 facts as tagged in accession 0001534424-17-000447.

This filing

Form
10-Q (quarterly report)
Filed
2017-11-06
Fiscal period
fiscal Q3 2017
Accession
0001534424-17-000447 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ClearPoint Neuro, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-09-3015,459,724USD
At 2016-12-317,400,885USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-09-308,179,445USD
At 2016-12-318,156,954USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-09-307,280,279USD
At 2016-12-31-756,069USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-09-3011,028,973USD
At 2016-12-313,315,774USD
At 2016-09-304,432,421USD
At 2015-12-315,408,523USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-1,425,519USD92
2017-01-01 to 2017-09-30-5,085,670USD273
2016-07-01 to 2016-09-30-2,563,231USD92
2016-01-01 to 2016-09-30-6,389,012USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-4,246,781USD273
2016-01-01 to 2016-09-30-4,708,157USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-01-01 to 2017-09-3024,515USD273
2016-01-01 to 2016-09-30100,324USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2017-07-01 to 2017-09-301,717,070USD92
2017-01-01 to 2017-09-305,700,147USD273
2016-07-01 to 2016-09-301,616,333USD92
2016-01-01 to 2016-09-304,114,349USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-09-3011,984,495USD273
2016-01-01 to 2016-09-303,832,379USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-24,515USD273
2016-01-01 to 2016-09-30-100,324USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-09-30-98,954,434USD
At 2016-12-31-93,868,764USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-09-30246,381USD
At 2016-12-31328,249USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-07-01 to 2017-09-30186,982USD92
2017-01-01 to 2017-09-30616,007USD273
2016-07-01 to 2016-09-30238,101USD92
2016-01-01 to 2016-09-30736,982USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-07-01 to 2017-09-30-1,327,323USD92
2017-01-01 to 2017-09-30-4,503,238USD273
2016-07-01 to 2016-09-30-1,709,522USD92
2016-01-01 to 2016-09-30-5,698,479USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-09-3014,313,302USD
At 2016-12-316,085,095USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-07-01 to 2017-09-30211,362USD92
2017-01-01 to 2017-09-30637,270USD273
2016-07-01 to 2016-09-30239,733USD92
2016-01-01 to 2016-09-30836,208USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-09-302,651,201USD
At 2016-12-313,017,700USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-09-30957,660USD
At 2016-12-311,546,926USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-09-30863,758USD
At 2016-12-31865,943USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-09-302,181,245USD
At 2016-12-311,768,382USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2017-07-01 to 2017-09-301,765,830USD92
2017-01-01 to 2017-09-305,731,961USD273
2016-07-01 to 2016-09-301,886,220USD92
2016-01-01 to 2016-09-305,748,524USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-07-01 to 2017-09-30589,716USD92
2017-01-01 to 2017-09-302,231,616USD273
2016-07-01 to 2016-09-30691,330USD92
2016-01-01 to 2016-09-302,098,465USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-09-3010,339,210shares
At 2016-12-313,622,032shares

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2017-09-304,793,619USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2017-09-3010,641USD
At 2016-12-3110,641USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2017-09-30239,326USD
At 2016-12-31134,996USD

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-01-01 to 2017-09-3092,656USD273
2016-01-01 to 2016-09-30125,076USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2017-07-01 to 2017-09-303,363USD92
2017-01-01 to 2017-09-306,774USD273
2016-07-01 to 2016-09-30-4,877USD92
2016-01-01 to 2016-09-30209,504USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2017-01-01 to 2017-09-30146,611USD273
2016-01-01 to 2016-09-30976,295USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-2,185USD273
2016-01-01 to 2016-09-30-414,506USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-09-30311,637USD273
2016-01-01 to 2016-09-3033,958USD274

Inspect the source

Entity
ClearPoint Neuro, Inc. / CIK 0001285550
Captured
2026-09-20T07:49:10.325Z
SEC response SHA-256
42cce1b4fae43ade1c2eab56e81afab6eae0d04e4ec290dc982d64b677ec31fb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001285550.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))